Clinical Trial Update: A Study To Assess The Effect Of PF-03526299 On Lung Function Following An Allergen Challenge In Asthmatic Subjects [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 study to evaluate the effect of PF-03526299 on lung function after an allergen challenge in asthmatic subjects; the trial status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PF-03526299

Snippet

Sponsor: Pfizer | Conditions: Asthma | Phase 1 | Status: COMPLETED